DrugCite
Search

TREANDA

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Treanda Adverse Events Reported to the FDA Over Time

How are Treanda adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Treanda, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Treanda is flagged as the suspect drug causing the adverse event.

Most Common Treanda Adverse Events Reported to the FDA

What are the most common Treanda adverse events reported to the FDA?

Pyrexia
485 (3.19%)
Neutrophil Count Decreased
357 (2.35%)
White Blood Cell Count Decreased
352 (2.32%)
Platelet Count Decreased
330 (2.17%)
Febrile Neutropenia
305 (2.01%)
Lymphocyte Count Decreased
301 (1.98%)
Rash
253 (1.66%)
Neutropenia
250 (1.64%)
Nausea
239 (1.57%)
Pancytopenia
235 (1.55%)
Anaemia
223 (1.47%)
Show More Show More
Pneumonia
209 (1.38%)
Thrombocytopenia
195 (1.28%)
Diarrhoea
185 (1.22%)
Cytomegalovirus Infection
176 (1.16%)
Fatigue
156 (1.03%)
Dyspnoea
151 (.99%)
Sepsis
144 (.95%)
Vomiting
127 (.84%)
Infection
124 (.82%)
Decreased Appetite
110 (.72%)
Hypotension
110 (.72%)
Chills
102 (.67%)
Death
101 (.66%)
C-reactive Protein Increased
100 (.66%)
Bone Marrow Failure
92 (.61%)
General Physical Health Deteriorati...
85 (.56%)
Tumour Lysis Syndrome
85 (.56%)
Haemoglobin Decreased
84 (.55%)
Pneumocystis Jiroveci Pneumonia
82 (.54%)
Asthenia
81 (.53%)
Herpes Zoster
77 (.51%)
Cough
76 (.5%)
Renal Failure Acute
75 (.49%)
Phlebitis
73 (.48%)
Leukopenia
71 (.47%)
Disease Progression
70 (.46%)
Lymphopenia
69 (.45%)
Renal Failure
68 (.45%)
Malaise
67 (.44%)
Dehydration
65 (.43%)
Blood Lactate Dehydrogenase Increas...
64 (.42%)
Pleural Effusion
64 (.42%)
Weight Decreased
63 (.41%)
Atrial Fibrillation
62 (.41%)
Haemolytic Anaemia
58 (.38%)
Extravasation
56 (.37%)
Lung Disorder
56 (.37%)
Pneumonitis
55 (.36%)
Alanine Aminotransferase Increased
52 (.34%)
Interstitial Lung Disease
52 (.34%)
Pulmonary Embolism
52 (.34%)
Blood Creatinine Increased
51 (.34%)
Constipation
50 (.33%)
Liver Disorder
50 (.33%)
Respiratory Failure
50 (.33%)
Stevens-johnson Syndrome
49 (.32%)
Stomatitis
49 (.32%)
Infusion Site Extravasation
48 (.32%)
Disseminated Intravascular Coagulat...
47 (.31%)
Septic Shock
46 (.3%)
Aspartate Aminotransferase Increase...
45 (.3%)
Pulmonary Oedema
45 (.3%)
Chronic Lymphocytic Leukaemia
44 (.29%)
Rash Maculo-papular
44 (.29%)
Hypokalaemia
43 (.28%)
Hypoxia
43 (.28%)
Hyperkalaemia
42 (.28%)
Hepatitis B
41 (.27%)
Tremor
41 (.27%)
Mantle Cell Lymphoma
40 (.26%)
Tachycardia
40 (.26%)
Bronchitis
39 (.26%)
Hepatic Function Abnormal
39 (.26%)
Oedema Peripheral
39 (.26%)
Infusion Site Pain
38 (.25%)
Progressive Multifocal Leukoencepha...
38 (.25%)
Rash Erythematous
38 (.25%)
Red Blood Cell Count Decreased
38 (.25%)
Staphylococcal Infection
38 (.25%)
Abdominal Pain
37 (.24%)
Chest Pain
37 (.24%)
Hypoalbuminaemia
37 (.24%)
Dizziness
36 (.24%)
Hypersensitivity
36 (.24%)
Pruritus
36 (.24%)
Multi-organ Failure
35 (.23%)
Myocardial Infarction
35 (.23%)
Syncope
35 (.23%)
Blood Bilirubin Increased
34 (.22%)
Hypercalcaemia
34 (.22%)
Rash Pruritic
34 (.22%)
Confusional State
33 (.22%)
Vasculitis
33 (.22%)
Anaemia Haemolytic Autoimmune
32 (.21%)
B-cell Lymphoma
32 (.21%)
Headache
32 (.21%)
Neuropathy Peripheral
32 (.21%)
Pain In Extremity
32 (.21%)
Urinary Tract Infection
32 (.21%)
Myelodysplastic Syndrome
31 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Treanda, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Treanda is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Treanda

What are the most common Treanda adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Treanda, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Treanda is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Treanda According to Those Reporting Adverse Events

Why are people taking Treanda, according to those reporting adverse events to the FDA?

Chronic Lymphocytic Leukaemia
1035
Non-hodgkins Lymphoma
587
B-cell Lymphoma
549
Mantle Cell Lymphoma
361
Multiple Myeloma
250
Lymphoma
203
Show More Show More
Diffuse Large B-cell Lymphoma
47
Small Cell Lung Cancer Stage Unspec...
41
B-cell Small Lymphocytic Lymphoma
33
Extranodal Marginal Zone B-cell Lym...
32
Drug Use For Unknown Indication
27
Hodgkins Disease
25
Product Used For Unknown Indication
23
Non-hodgkins Lymphoma Recurrent
23
Breast Cancer
22
Mantle Cell Lymphoma Recurrent
22
Waldenstroms Macroglobulinaemia
22
Breast Cancer Metastatic
20
Acute Myeloid Leukaemia
19
Diffuse Large B-cell Lymphoma Refra...
19
Acute Leukaemia
18
Lymphoplasmacytoid Lymphoma/immunoc...
17
Splenic Marginal Zone Lymphoma
15
Non-hodgkins Lymphoma Unspecified H...
15
Malignant Lymphoid Neoplasm
15
Nodal Marginal Zone B-cell Lymphoma
14
Chronic Lymphocytic Leukaemia Recur...
14
Chemotherapy
13
Plasmacytoma
9
B-cell Lymphoma Recurrent
9
Lymphocytic Leukaemia
7
Acute Lymphocytic Leukaemia
7
Diffuse Large B-cell Lymphoma Recur...
6
Adult T-cell Lymphoma/leukaemia
6
Prolymphocytic Leukaemia
6
Hairy Cell Leukaemia
6
Chronic Lymphocytic Leukaemia Refra...
5
Follicle Centre Lymphoma, Follicula...
4
Mantle Cell Lymphoma Stage Iv
4
Chronic Leukaemia
4
Non-hodgkins Lymphoma Stage Iv
4
Neoplasm Malignant
4
Myelodysplastic Syndrome
3
Lung Neoplasm Malignant
3
Leukaemia
3
T-cell Lymphoma
3
Plasmablastic Lymphoma
3
Small Cell Lung Cancer Extensive St...
3
Myeloma Recurrence
3
Nodal Marginal Zone B-cell Lymphoma...
2
Bone Marrow Conditioning Regimen
2

Drug Labels

LabelLabelerEffective
TreandaCephalon, Inc.26-JUN-12

Treanda Case Reports

What Treanda safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Treanda. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Treanda.